"A Study to Compare the Pharmacokinetics and the Safety Between a Fixed-dose Combination Administration of BR3005 and Co-administration of BR3005-1 and BR3005-2 Under Fasting Conditions in Healthy Adult Volunteers"

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 2, 2024

Primary Completion Date

March 28, 2024

Study Completion Date

March 28, 2024

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

BR3005

One tablet administered alone, Once a day

DRUG

BR3005-1

One tablet administered alone, Once a day

DRUG

BR3005-2

One tablet administered alone, Once a day

Trial Locations (1)

Clinical Research Center, H PLUS Yangji Hospital, Seoul